Literature DB >> 30354724

IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure.

Rana Ghali1, Raffaele Altara2,3,4, William E Louch2,3, Alessandro Cataliotti2,3, Ziad Mallat5,6, Abdullah Kaplan1, Fouad A Zouein1, George W Booz7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30354724     DOI： 10.1161/HYPERTENSIONAHA.118.11157

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.

Authors:  Catherine E Simpson; Rachel L Damico; Paul M Hassoun; Lisa J Martin; Jun Yang; Melanie K Nies; R Dhananjay Vaidya; Stephanie Brandal; Michael W Pauciulo; Eric D Austin; D Dunbar Ivy; William C Nichols; Allen D Everett
Journal:  Chest       Date:  2020-01-25       Impact factor: 9.410

2.  RNAseq shows an all-pervasive day-night rhythm in the transcriptome of the pacemaker of the heart.

Authors:  Yanwen Wang; Cali Anderson; Halina Dobrzynski; George Hart; Alicia D'Souza; Mark R Boyett
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

3.  IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.

Authors:  Se Yun Cheon; Jong Ho Park; Amir H Ameri; Richard T Lee; Rosalynn M Nazarian; Shadmehr Demehri
Journal:  J Invest Dermatol       Date:  2022-03-25       Impact factor: 7.590

Review 4.  Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Anca Ouatu; Ciprian Rezus; Manuela Ciocoiu; Claudia Florida Costea; Mariana Floria
Journal:  Int J Hypertens       Date:  2019-05-02       Impact factor: 2.420

5.  Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies.

Authors:  Falk Diedrichs; Meaghan Stolk; Karsten Jürchott; Marion Haag; Michael Sittinger; Martina Seifert
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

6.  Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1.

Authors:  Lara Matilla; Vanessa Arrieta; Eva Jover; Amaia Garcia-Peña; Ernesto Martinez-Martinez; Rafael Sadaba; Virginia Alvarez; Adela Navarro; Amaya Fernandez-Celis; Alicia Gainza; Enrique Santamaria; Joaquín Fernandez-Irigoyen; Patrick Rossignol; Faiez Zannad; Natalia Lopez-Andres
Journal:  Cells       Date:  2020-07-10       Impact factor: 6.600

7.  Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis.

Authors:  Yang Zhang; Ying Xiao; Yongtai Liu; Quan Fang; Zhuang Tian; Jian Li; Daobin Zhou; Zhongpeng Xie; Ruijia Dong; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2021-01-20

8.  The Role of Pro-Inflammatory and Regulatory Signaling by IL-33 in the Brain and Liver: A Focused Systematic Review of Mouse and Human Data and Risk of Bias Assessment of the Literature.

Authors:  Nika Zharichenko; Dolores B Njoku
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 9.  Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era.

Authors:  Aneta Aleksova; Gianfranco Sinagra; Antonio P Beltrami; Alessandro Pierri; Federico Ferro; Milijana Janjusevic; Giulia Gagno
Journal:  ESC Heart Fail       Date:  2021-10-05

10.  Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure.

Authors:  Antonino Tuttolomondo; Carlo Maida; Alessandra Casuccio; Domenico Di Raimondo; Roberto Fonte; Valerio Vassallo; Maria Grazia Puleo; Tiziana Di Chiara; Alba Mogavero; Alessandro Del Cuore; Mario Daidone; Antonella Ortello; Antonio Pinto
Journal:  ESC Heart Fail       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.